TechConnect Innovation Program

PROTEOMARKERS BIOTECH (PMB)

Biomedical Research Foundation of the Academy of Athens, Αττιψα, Greece

TECHNOLOGY SUMMARY

An innovative biotechnology-oriented company specialiζed in the design and production of screening tests for mass spectrometric protein marker (biomarker) detection, for the non-invasive diagnosis of chromosomal-dependent (Down syndrome, Turner syndrome etc) and chromosomal-independent (pre-eclamsia, premature delivery, intra-uterine infections), pregnancy complications.

Primary Application Area: Biotech & Biological Sciences

Technology Development Status: Prototype

Technology Readiness Level: TRL 4

FIGURES OF MERIT

Value Proposition: High accuracy and sensitivity
Sort time for the result
Low cost compared to other non-invasive prenatal methods
Innovation, because mass spectrometry will be the diagnostic method for the future.

SHOWCASE SUMMARY

Organization Type: Early-stage Startup (Seed)

Showcase Booth #: 650

Website: www.bioacademy.gr

GOVT/EXTERNAL FUNDING SOURCES

Government Funding/Support to Date:

Primary Sources of Funding: Angel, Friends, Family

Looking for: Funding